Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cellular reactive oxygen species (ROS) system and redox environment represent a complex network of pro-oxidant and antioxidant molecules that maintain cellular homeostasis (Sies & Jones, 2020). ROS, such as superoxide and hydrogen peroxide, are generated primarily by the mitochondrial respiratory chain and enzymes like NADPH oxidases (NOX) (Di Meo et al., 2016). While ROS are essential for physiological signaling processes, including immune response and cell differentiation, an imbalance known as oxidative stress leads to the damage of lipids, proteins, and DNA (Forman & Zhang, 2021). This system is implicated in the pathogenesis of numerous conditions, including cancer, neurodegenerative diseases like Alzheimer's, and cardiovascular disorders (NIH, 2023). Pharmacological intervention typically involves the use of antioxidants to scavenge radicals or the activation of the Nrf2 pathway to boost endogenous defenses (PubChem). However, therapeutic targeting is complicated by the antioxidant paradox, where non-specific ROS reduction can interfere with vital signaling pathways (Halliwell, 2011). Modern drug discovery focuses on specific enzymes within this system, such as NOX isoforms or superoxide dismutase mimetics, to achieve more precise therapeutic effects (Schieber & Chandel, 2014). Monitoring the redox state often involves measuring lipid peroxidation products or the ratio of reduced to oxidized glutathione (GSH/GSSG) (Jones, 2006).
Drugs targeting the cellular redox environment function by directly neutralizing reactive species, inhibiting enzymatic sources of ROS production, or inducing the expression of cytoprotective antioxidant enzymes via the Nrf2-KEAP1 signaling axis.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular reactive oxygen species system (ROS system).